Medical Director Strategist at Azurity Pharmaceuticals

Raleigh, North Carolina, United States

Azurity Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Doctoral-level qualification (PharmD, PhD, MD, DO) required
  • 5+ years of Medical Affairs experience in the pharmaceutical or biotech industry
  • Excellent communication, analytical, and strategic thinking skills
  • Proven ability to communicate and present effectively to senior leaders and cross-functional teams
  • Demonstrated success in lifecycle management and cross-functional leadership
  • Strong understanding of clinical research, regulatory frameworks, and healthcare market dynamics

Responsibilities

  • Provide medical input throughout the product life cycle management (PLM) process, in close collaboration with the Franchise Portfolio Management (FPM) and Commercial teams
  • Lead development of Medical Affairs global strategic and tactical plans across all stages of a product’s lifecycle and across multiple therapeutic areas
  • Identify evidence generation needs early in the product lifecycle to support regulatory requirements for drug approval, clinical differentiation, and market access discussions (e.g., RWE, HEOR studies)
  • Oversee post-marketing commitments to maintain product relevance and compliance
  • Lead Medical budget planning to ensure the appropriate level of investment to support launch success
  • Shape products’ scientific narrative to ensure initial market priming and products' share of voice (e.g., scientific platform, key messages)
  • Lead global Advisory Board meetings to inform and validate medical strategy and key scientific messages for products
  • Work closely with Medical Science Liaisons (MSLs) to gather and synthesize insights from healthcare professionals and market data to inform lifecycle decisions
  • Collaborate with all functional areas of global Medical Affairs organization to ensure successful execution of tactical plans/Medical activities
  • Ensure scientific excellence throughout the product lifecycle, from early development through launch, maturity, and eventual sunset
  • Manage vendors involved with key projects, including project timelines and budgets

Skills

Medical Affairs
Medical Strategy
Evidence Generation
Publication Planning
Stakeholder Engagement
Product Lifecycle Management
Cross-functional Collaboration
Franchise Portfolio Management

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters
2000Year Founded
$182.2MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Hybrid Work Options
Professional Development Budget
Tuition Reimbursement
Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.
Integration challenges from Slayback Pharma acquisition may disrupt operations.
Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.
Their FDA-approved products ensure safety and efficacy in specialized formulations.
Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.
Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.
FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI